Man Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Man Group's PCRX Position: Q3 2026 in Review
Man Group reduced its Pacira BioSciences (PCRX) stake by 9.3% in Q3 2026, selling an estimated $295K and leaving 113,732 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1389.
Man Group first reported a position in PCRX in Q2 2018 and has held it in 21 quarters since. The position peaked at $11.9M in Q3 2020. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Man Group held 113,732 shares of Pacira BioSciences worth $2.85M as of Q3 2026.
- Man Group sold 11,638 Pacira BioSciences shares in Q3 2026, an estimated $295K.
- Pacira BioSciences made up ﹤0.01% of Man Group's portfolio in Q3 2026, its #1389 holding.
- Man Group first reported a position in Pacira BioSciences in Q2 2018 and has held it in 21 quarters since.
- Man Group's Pacira BioSciences position peaked at $11.9M in Q3 2020.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Man Group's 13F filing for Q3 2026, filed 16 Nov 2026.